National Biological Corporation

National Biological Corporation, a for-profit medical equipment manufacturer based in Beachwood, Ohio, supplies phototherapy systems and related electromedical devices to federal healthcare agencies as a prime contractor exclusively—all 466 recent awards are prime contracts with no subcontract footprint. The company competes full-and-open on the GSA Medical Equipment and Supplies Schedule (FSS-65-II-A), with no set-aside designations recurrent across its prime portfolio, though two awards carry Total Small Business set-asides.

National Biological Corporation's capability portfolio centers on phototherapy booths, clinical phototherapy units, and phototherapy equipment repair and maintenance for dermatology and clinical settings. Representative work includes a $26.9 thousand delivery order from the Department of Veterans Affairs Veterans Integrated Service Network 8 for a HOUVA 4 Phototherapy System (September 2025), a $25.7 thousand order from VISN 2 for a phototherapy booth and installation at a New Jersey dermatology clinic (April 2025), a $32.9 thousand delivery order from the Defense Health Agency for a Model UVB-101 HOUVA II UVB narrow-band phototherapy booth (April 2023), and a $14.6 thousand repair and maintenance contract from VISN 19 (September 2023). The company's product line focuses on the HOUVA series of phototherapy systems and related accessories, with awards spanning delivery orders, purchase orders, and ongoing equipment maintenance.

Customer concentration is extreme and centered on the Department of Veterans Affairs. The top five funding agencies by potential-value share account for 76 percent of combined potential value, dominated by VISN 12 (8 awards, $5.8 million combined potential value), which anchors the portfolio. By award count, the top five VISNs—VISN 23, VISN 4, VISN 10, VISN 7, and VISN 8—collectively represent only 24 percent of awards but each carries 18 to 36 individual orders, signaling a high-volume, low-dollar-per-order pattern typical of medical equipment distribution. The Defense Health Agency appears in both rankings as the only significant non-VA customer (5 awards, $126 thousand combined potential value). Across 29 distinct customer agencies served, the VA healthcare network and Defense Health Agency dominate.

National Biological Corporation places all task orders under the GSA Medical Equipment and Supplies Schedule (FSS-65-II-A); 202 task orders under this vehicle carry $1.5 million in combined potential value. The company has no presence on other IDIQs, GWACs, or agency-specific contract vehicles beyond GSA Schedule. Activity has been sparse and flat over the trailing five years—two awards in 2021 and 2022, five in 2023, five in 2025, and one in 2026—with only one award facing recompete completion within the next twenty-four months. Combined potential value across the portfolio sits at $8.4 million, with $2.8 million (33 percent) obligated to date. Primary NAICS categories are Electromedical and Electrotherapeutic Apparatus Manufacturing (218 awards) and Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (94 awards); primary PSC is Medical And Surgical Instruments, Equipment, And Supplies (272 awards).